No One Is Leading Our Health Agencies.
New York Times
Last updated: May 15, 2026
The Department of Health and Human Services (HHS) has experienced significant leadership instability over the last 16 months. This has led to frequent changes in leadership roles, impacting the continuity of departmental operations and policy implementation.
- The article highlights a period of frequent leadership transitions within the Department of Health and Human Services (HHS), spanning approximately 16 months. This rapid turnover has affected key positions, including the Food and Drug Administration (FDA). Dr. Marty Makary's resignation from his role as head of the FDA is noted as a significant event within this period of flux. The article implies that such frequent changes can disrupt established strategies and operational efficiency within these critical governmental bodies. The repeated shifts in leadership suggest potential challenges in maintaining consistent policy direction and program execution. The overall picture painted is one of ongoing organizational change at the highest levels of HHS, with implications for public health initiatives and regulatory oversight.
